Davunetide: a review of safety and efficacy data with a focus on neurodegenerative diseases.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Davunetide: a review of safety and efficacy data with a focus on neurodegenerative diseases.
- Published In:
- Expert review of clinical pharmacology, 6(5), 483-502 (2013)
- Database ID:
- RPEP-02239
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02239APA
Morimoto, Bruce H; Fox, Anthony W; Stewart, Alistair J; Gold, Michael. (2013). Davunetide: a review of safety and efficacy data with a focus on neurodegenerative diseases.. Expert review of clinical pharmacology, 6(5), 483-502. https://doi.org/10.1586/17512433.2013.827403
MLA
Morimoto, Bruce H, et al. "Davunetide: a review of safety and efficacy data with a focus on neurodegenerative diseases.." Expert review of clinical pharmacology, 2013. https://doi.org/10.1586/17512433.2013.827403
RethinkPeptides
RethinkPeptides Research Database. "Davunetide: a review of safety and efficacy data with a focu..." RPEP-02239. Retrieved from https://rethinkpeptides.com/research/morimoto-2013-davunetide-a-review-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.